Medifast, Inc.
MED
$10.53
$0.100.96%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -701.37% | -191.17% | 421.24% | -196.38% | -28.93% |
| Total Depreciation and Amortization | 0.38% | -14.66% | 23.32% | 2.98% | -0.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 742.81% | 100.76% | -65.29% | 165.69% | -213.48% |
| Change in Net Operating Assets | -169.22% | 183.72% | -512.79% | 63.76% | -514.63% |
| Cash from Operations | -143.57% | 458.58% | -199.18% | 168.85% | -154.53% |
| Capital Expenditure | 0.88% | 1.09% | 9.46% | 33.39% | -64.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 72.14% | -187.67% | 2,869.74% | 96.90% | -4,273.98% |
| Cash from Investing | 65.34% | -206.92% | 750.29% | 89.43% | -990.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | 99.73% | -36,800.00% | 50.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 100.00% | 99.48% | -- | 100.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00% | 99.64% | -56,200.00% | 66.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -371.54% | -121.73% | 1,164.51% | 103.24% | -434.37% |